COMPUTED DESCRIPTORS
| Molecular Weight | 1506.4 g/mol |
|---|---|
| Hydrogen Bond Donor Count | 14 |
| Hydrogen Bond Acceptor Count | 25 |
| Rotatable Bond Count | 30 |
| Exact Mass | 1505.4486636 g/mol |
| Monoisotopic Mass | 1505.4486636 g/mol |
| Topological Polar Surface Area | 556 Ų |
| Heavy Atom Count | 98 |
| Formal Charge | 0 |
| Complexity | 2570 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 10 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 3 |
| Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
description
Indium In-111 Pentetreotide is an indium 111 radioconjugate of pentetreotide, the diethylenetriaminopentaacetic (DTPA) conjugate of the human hormone somatostatin peptide analogue (octreotide), used for radioimaging neuroendocrine tumor cells. The pentetreotide moiety of indium In 111 pentetreotide binds to somatostatin receptors (SSTRs), especially type 2 receptors, present on the cell membranes of many types of neuroendocrine tumor cells. Upon binding and internalization, this radioconjugate allows for specific imaging of neuroendocrine tumors that overexpress somatostatin using scintigraphic imaging techniques. In addition, high dose indium In 111 pentetreotide may specifically deliver a cytotoxic dose of gamma radiation to SSTR-positive cells thereby killing SSTR-expressing tumor cells.